Researchers discover variants of natural tumor suppressor

Building on their 2005 discovery of an enzyme that is a natural tumor suppressor, researchers at the University of California, San Diego School of Medicine have now identified two variants of that enzyme which could provide new targets for therapies to treat diabetes, heart and neurological disease. The findings, by Alexandra C. Newton, Ph.D., UCSD professor of pharmacology, and colleagues are published in the current edition of the journal Molecular Cell.

Previous research by Newton's lab, also published in Molecular Cell, described the discovery of an enzyme they named PH domain Leucine-rich repeat Protein Phosphatase (PHLPP, pronounced "flip") that turns off signaling of the Akt/protein kinase B, a protein which controls cell growth, proliferation and survival.

The new work describes a second family member, PHLPP2, which also inactivates Akt, inhibiting the cell cycle progression and promoting cell death. However, PHLPP1 and PHLPP2 control three different disease pathways. While both are important in cancer, PHLPP 1 impacts an important pathway in diabetes and PHLPP2 could be useful in fighting heart and neurological disease.

"We first discovered that PHLPP controls Akt, which is the driver on the pathway to tumor growth," said Newton. "PHLPP is like a brake that, when on, slows the driver but when 'off' allows the driver to move. In cancer, we want the driver to brake, to prevent cell proliferation leading to tumor growth. But in diabetes, heart or neurological disease, where we want to promote cell growth and survival, we don't want to slow the driver down."

The researchers have now found that PHLPP1 controls the driver along one pathway – Akt2, which is more closely involved in maintaining a constant level of glucose in the bloodstream. Therapies directed at inhibiting PHLPP1 could be used to treat diabetes; in essence, removing the 'brake' and allowing Akt2 to be more functional and allow better insulin regulation. PHLPP2, on the other hand, controls the driver on Akt1, the path involved with cell survival. Therapies directed at releasing the brake on this driver would allow cells involved in heart or neurological diseases to better survive.

"Both PHLPP variants are important in cancer; the loss of a brake to any of the three Akt pathways sends 'go, go, go' signals that promote the survival of tumor cells," said first author John Brognard. UCSD researchers had previously discovered that Akt is hyperactivated, or elevated, in most cancers and PHLPP provides a mechanism to reverse this activation.

Source: University of California - San Diego

Related stories:

Alzheimer's disease as a case of brake failure?
A loss of protein function in neurons may lead to dementia
Rutgers researcher Karl Herrup and colleagues at Case Western Reserve University have discovered that a protein that suppresses cell division in brain cells effectively "puts the brakes" on the dementia that comes with Alzheimer's disease (AD). When the brakes fail, dementia results.
Driving while phoning danger as bad as drink-driving
Motorists who use cellphones while driving make as many, if not more, driving errors as clinically drunk drivers, according to educational psychologist Professor Michael Townsend. He says the proposed ban on hand-held cellphone use by drivers is long overdue.
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
Research led by scientists at Cincinnati Children's Hospital Medical Center has revealed new clues into what causes different types of a particularly aggressive group of blood cancers known as mixed lineage leukemias (MLL) and how the disease might be treated, according to a study in the June 9 issue of Cancer Cell.
Magnetic Sensor That Brooks No Interference
Sensors accurately register the slightest temperature fluctuations, the tiniest changes to a magnetic field, or barely perceptible air currents. In some cases, however, there are limits to their accuracy – for instance when a sensor is supposed to register a small fluctuation to a magnetic field in a place where a strong magnetic field already exists.
Connecting cancer genes
A large genetic study in mice has identified hundreds of genes involved in the development of cancer by examining the DNA of more than 500 lymphomas to find the cancer causing mutations.
Yeast gives rise to new concept: cell fuel is 'brains' behind division
With the cost of diesel and gasoline getting nearer to the hourly minimum wage, too bad the fuel doesn’t do more work - like deciding what route to take and pressing the gas pedal.
Ultra-Fast Quantum-Dot Information Storage
The information-storage market is dominated by two main types: Flash memory, used in memory sticks and cell phones, and dynamic random access memory (DRAM), which is the main memory in a personal computer. Both types have their advantages and disadvantages, but a new type of memory, based on tiny atom clusters, called quantum dots, may soon displace both of them.
Policing cells demand ID to tell friend from foe
University of Pennsylvania scientists studying macrophages, the biological cells that spring from white blood cells to eat and destroy foreign or dying cells, have discovered how these “policemen” differentiate between friend and foe. The paper appears as the cover article in the March 10 edition of the Journal of Cell Biology.

News discussion:

Medicine & Health news